ARTICLE
TITLE

Serum biomarkers for early detection of gynecologic cancers

SUMMARY

Ovarian, endometrial, and cervical cancers are three of the most common malignancies of the female reproductive organs. CA 125, historically the most reliable serum marker for ovarian cancer, is elevated in 50% of early-stage ovarian tumors. For endometrial cancers, there are no established serum markers. SCC, which is the best studied serum marker for squamous cell carcinomas, has been unreliable; SCC is elevated in cervical squamous cell carcinomas ranging from 28–85% of the time. Recent proteomics-based analyses show great promise for the discovery of new and more useful biomarkers. In this review, we discuss the currently utilized serum tumor markers for gynecologic cancers and the novel biomarkers that are now under investigation.

PAGES
pp. 73 - 80

 Articles related

Shiavax J. Rao, Andrew J. Boileau    

Alzheimer’s disease is a neurodegenerative condition associated with neurofibrillary tangles and cortical deposition of amyloid plaques. Clinical presentation of the disease involves manifestations such as memory loss, cognitive decline and dementia with... see more


Ravibabu Kalahasthi,Tapu Barman,Bhavani Shankara Bagepally    

Background: The major portion of lead in the body resides in skeletal system. The bone turnover affects the release of lead into the circulation from bones. The bone turnover biomarkers (BTM) in lead-battery workers with long-term exposure to lead have n... see more


Benash Altaf, Anam Rehman, Shireen Jawed, Abdul Raouf    

Objective: To investigate the association of gold standard liver biomarkers with serum cytokeratin 18 (CK18), serum Alanine aminotransferase (ALT) and serum aspartate (AST).Methods: This was cross sectional study. It was conducted at Mayo Hospital from J... see more


Anna Meiliana,Andi Wijaya    

BACKGROUND: The investigation of novel circulating serum and plasma biomarkers in patients with cardiovascular disease has been accelerating at a remarkable pace. New markers or tests are often presented too early to the medical profession, potentially l... see more


Bin Lu, PhD,Martin Sanda, MD    

Cancer is a diverse disease and each cancer has different mechanism. To find a highly sensitive and specific biomarker that can reflect a single cancer, is a challenge for detection or therapeutic purpose. Gene expression profiling, proteomics, and immun... see more